Condensed heteroaryl derivatives

A technology of condensing heteroaryl and derivatives, applied in the field of condensing heteroaryl derivatives, can solve problems such as no explanation, no disclosure of PI3K inhibitory effect and anticancer effect, etc.

Inactive Publication Date: 2003-06-25
ASTELLAS PHARMA INC +2
View PDF15 Cites 31 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, the PI3K inhibitory effect and anticancer effect are neither disclosed nor explained in these existing documents.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

experiment example 1

[0148] Experimental example 1 Inhibition experiment of PI3K (p110α subtype)

[0149] The assay was performed with an enzyme (bovine p110α) produced by a baculovirus expression system. Enzymes were prepared according to "Cell (Cell)" by I Hile et al., 70, 419, 1992. Compounds to be evaluated were prepared as 10 mM (millimolar) DMSO solutions and serially diluted with DMSO.

[0150] Compounds (0.5 μl) and enzymes were evaluated in 25 μl buffer (40 mM Tris-HCl (pH 7.4), 200 mM NaCl, 2 mM dithiothreitol, 5 mM MgCl 2 ) after mixing, add 10 micrograms of PI (Sigma), 2µCi (microcurie) [γ- 32 P] ATP (Amersham Pharmacia), 80 μM (micromolar) non-radioactive ATP (Sigma) in 25 μl of 5 mM Tris-HCl (pH 7.4) buffer, the reaction was initiated. After reacting at 37°C for 15 minutes, add 200 μl of 1M HCl, 400 μl of CHCl 3 / MeOH (1:1), stirring, centrifugation. The organic layer was extracted two more times with 150 microliters of MeOH / 1M HCl (1:1), and its radioactivity was measured by C...

experiment example 2

[0154] Experimental Example 2 Intestinal Cancer Cell Proliferation Inhibition Experiment

[0155] Intestinal cancer cell line HCT116 was cultured in McCoy's 5A medium (GIBCO) containing 10% fetal bovine serum. HCT116 (5000 cells / well) was inoculated on a 96-well plate and cultured overnight. Compounds diluted with culture medium were added thereto to a final concentration of 0.1-30 μM (final DMSO concentration, 1%). After culturing for 72 hours, Alamar Blue reagent was added. After 2 hours, the inhibitory activity IC was obtained from the fluorescence intensity ratio of the excitation wavelength of 530 nm and the emission wavelength of 590 nm 50 . of the present invention Co 14 , Co 24 , Co 25 , Co 31 , Co 46 with Co 47 The compound has a good inhibitory effect on cancer cell proliferation.

experiment example 3

[0156] Experimental Example 3 Proliferation Inhibition Experiment of Melanoma Cells

[0157] Melanoma cell line A375 cells were cultured in DMEM medium (GIBCO) containing 10% fetal bovine serum. A375 cells were pre-seeded at 10000 cells / 100 microliters on a 96-well plate containing 1 microliter per well (final concentration 0.001-30 microliters). After 46 hours of incubation, Alamar Blue reagent (10 μl / well) was added. After 2 hours, use the same method as above to determine the IC of the test compound from the fluorescence intensity ratio of the excitation wavelength of 530 nm and the emission wavelength of 590 nm 50 .

[0158] The compounds of the present invention have good growth inhibitory activity. E.g, Co 17 , Co 33 , Co 50 , Co 69 , Co 164 , Co 172 , Co 174 , Co 186 , Co 190 with Co 191 It has a good inhibitory effect on the proliferation of melanoma cells. its IC 50 Values ​​were 0.33-4.26 μM. The value of LY294002, which is a well-known ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

Medicinal compositions which are useful as phosphatidylinositol 3-kinase (PI3K) inhibitors and anticancer agents; and novel bicyclic or tricyclic condensed heteroaryl derivatives or salts thereof having favorable effects of inhibiting PI3K and suppressing the proliferation of cancer cells.

Description

technical field [0001] The present invention relates to fused heteroaryl derivatives useful as pharmaceuticals, especially phosphatidylinositol 3-kinase (PI3K) inhibitors and anticancer agents. Background technique [0002] Phosphatidylinositol (hereinafter referred to as "PI") is one of cell membrane phospholipids, which is known to play a role in intracellular information transmission. In particular, it is well understood that PI(4,5) diphosphate (PI(4,5)P2) is broken down by phospholipase C into diacylglycerol and inositol (1,4,5) triphosphate, causing Activation of protein kinase C and intracellular calcium mobilization [MJ Berridge et al., Nature, 312, 315, (1984), Y Nishizuka, Science, 225, 1365 (1984)]. [0003] On the other hand, in the second half of the 1980s, PI3K was identified as an enzyme that phosphorylates the 3-position of the PI-inositol ring [D Whitman et al., Nature, 332, 664 (1988)]. [0004] PI3K was once thought to be a single enzyme when it was firs...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/4355A61K31/4365A61K31/437A61K31/444A61K31/519A61K31/5377A61P35/00A61P43/00C07D491/04C07D491/048C07D491/147
CPCA61K31/437C07D491/04A61K31/519A61K31/4365A61K31/5377A61K31/444A61K31/4355A61P1/18A61P13/08A61P13/12A61P17/06A61P19/08A61P27/06A61P29/00A61P3/10A61P35/00A61P43/00A61P9/10
Inventor 早川昌彦贝沢弘行森友博幸川口贤一小泉智信山野真由美松田光阳冈田稔太田光昭
Owner ASTELLAS PHARMA INC
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap